Seminar: Developability Assessment of therapeutic Antibodies - A concept for early Lead Selection | Thorsten Lorenz, PhD - Novartis Pharma AG
31 May 2016 - 12:0013:00 • iBET|ITQB Auditorium, OeirasiBET – ITQB SEMINAR
Thorsten Lorenz, PhD
“Developability Assessment of therapeutic Antibodies - A concept for early Lead Selection”
Group Head Developability Assessment 1, Integrated Biologics Profiling, Novartis Pharma AG, Basel – Switzerland.
Host: Manuel Carrondo
ITQB Auditorium
31 May, 2016 from 12:00 pm to 01:00 pm